Table 1b.
Summary of phosphopeptidesa identified and their changes in abundance in response to treatment
Changed Compared to Control |
||||||
---|---|---|---|---|---|---|
Phospho-Peptides | Peptides unique to treatment | ANOVA (P<0.05) | >2 fold spectral count increase | >2 fold spectral count decrease | Phospho Peptides % | |
Control | 648 | 42 | 90.8 | |||
250 μM Hg2+ | 969 | 374 | 337 | 43 | 70 | 92.5 |
Okadaic acid | 724 | 67 | 71 | 7 | 9 | 93.2 |
Control | 600 | 85 | 97.6 | |||
100 μM Hg2+ | 596 | 70 | 65 | 7 | 7 | 98.0 |
pervanadate | 691 | 211 | 212 | 45 | 31 | 98.0 |
All phosphopeptides were assigned to a protein in table 1a